Veterinary Medicines

NOBILIS E.COLI INAC

Authorised
  • Escherichia coli, flagellar toxin
  • Escherichia coli, fimbrial adhesin F11
Download as PDF

Product identification

Medicine name:
NOBILIS E.COLI INAC
Nobilis E. coli Inac emulsie voor injectie voor kippen
Active substance:
  • Escherichia coli, flagellar toxin
  • Escherichia coli, fimbrial adhesin F11
Target species:
  • Chicken
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Escherichia coli, flagellar toxin
    100.00
    microgram(s)
    /
    1.00
    Dose
  • Escherichia coli, fimbrial adhesin F11
    100.00
    microgram(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        35
        day
      • Egg
        0
        day
  • Subcutaneous use
    • Chicken
      • Meat and offal
        35
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AB05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • 250 ml (500 doses) in one glass type II vial closed with a nitryl rubber stopper and sealed with a coded aluminium cap in a cardboard box.
  • 500 ml (1000 doses) in one glass type II vial closed with a nitryl rubber stopper and sealed with a coded aluminium cap in a cardboard box.
  • 500 ml (1000 doses) in one PET vial closed with a nitryl rubber stopper and sealed with a coded aluminium cap in a cardboard box.
  • 250 ml (500 doses) in one PET vial closed with a nitryl rubber stopper and sealed with a coded aluminium cap in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 8266
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0017/001
Concerned member states:
  • Austria
  • Belgium
  • France
  • Germany
  • Greece
  • Ireland
  • Italy
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 19/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."